http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference
-
MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
-
MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
-
MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results
-
Agenus Provides Corporate Update and First Quarter 2023 Financial Results
-
MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
-
MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results
-
MiNK Therapeutics (INKT) Announces Clinical Data on agenT-797
-
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
-
MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting
-
Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
-
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
-
MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting
-
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
-
MiNK Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results
-
MiNK Therapeutics to Participate in HC Wainwright Cell Therapy Virtual Conference
-
MiNK Therapeutics to Participate in B. Riley Securities Oncology Conference
-
MiNK Therapeutics to Participate in Evercore ISI HealthCONx Conference
-
MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
-
Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
-
Agenus Corporate Update and Fourth Quarter & Full Year 2021 Financial Report
-
Agenus Corporate Update and Third Quarter 2021 Financial Report
-
Agenus Corporate Update and Third Quarter 2021 Financial Report
-
MiNK Therapeutics to Present Three Abstracts on Novel Allogeneic iNKT Programs at SITC